Newsroom
Sorted by: Latest
-
FDA Grants Orphan Drug Designation to Affinia Therapeutics’ AFTX-201 for the Treatment of BAG3-Associated Dilated Cardiomyopathy (DCM)
WALTHAM, Mass.--(BUSINESS WIRE)--Affinia Therapeutics (“Affinia”), an innovative clinical-stage gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating cardiovascular diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation for AFTX-201 for the treatment of BAG3-associated dilated cardiomyopathy (DCM). A potential best-in-class investigational genetic m...
-
Howard Energy Partners Announces Launch of $600 Million Offering of Senior Notes
SAN ANTONIO--(BUSINESS WIRE)--Howard Midstream Energy Partners, LLC (the “Company”) today announced that it is commencing an offering (the “Offering”) of $600 million of senior notes due 2035 (the “2035 Notes”). The 2035 Notes will be issued in a private offering exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). The Company will use the net proceeds from the Offering to (i) fund the repayment of a portion of outstanding borrowings under the Company’s...
-
Ranpak to Hold Conference Call to Discuss Second Quarter 2026 Results
CONCORD TOWNSHIP, Ohio--(BUSINESS WIRE)--Ranpak to Hold Conference Call to Discuss Second Quarter 2026 Results on Thursday, July 30, 2026....
-
Zai Lab to Announce Second Quarter 2026 Financial Results and Recent Corporate Updates on August 6, 2026
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its second quarter 2026 financial results and provide recent corporate updates on August 6, 2026, before the opening of U.S. equity markets. The announcement will be followed by a conference call and webcast at 8:00 a.m. ET (8:00 p.m. HKT). Conference Call and Webcast Information The live webcast can be accessed by visiting the Company's website at http://ir.zailaboratory...
-
Madison River Capital Partners with Pro-Max to Accelerate Growth of Premier Provider of Construction Services
NEW YORK & MIAMI--(BUSINESS WIRE)--Madison River Capital ("MRC"), a lower middle market private equity firm, today announced a strategic investment in Pro-Max ("Pro-Max" or the "Company"), a leading provider of structural repair, restoration, painting, and roofing solutions for condominium and commercial properties. The investment will support Pro-Max's geographic expansion, broadened service capabilities, and continued team development as the Company capitalizes on growing demand for high-qual...
-
Gibraltar to Announce Second Quarter 2026 Financial Results on August 5
BUFFALO, N.Y.--(BUSINESS WIRE)--Gibraltar Industries, Inc. (Nasdaq: ROCK), a leading manufacturer and provider of products and services for the residential, agtech and infrastructure markets, announced today that it expects to release its second quarter 2026 financial results at approximately 7:30 a.m. ET on Wednesday, August 5, 2026. It also expects to discuss the results on a conference call that will be webcast live that same day starting at 9:00 a.m. ET. Hosting the call will be Chief Execu...
-
Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced topline results for the global Phase 3 SHASTA-3 and SHASTA-4 clinical studies of plozasiran in patients with severe hypertriglyceridemia (sHTG), a condition that significantly increases the risk of acute pancreatitis (AP), which is associated with repeated hospital admissions and can be fatal. SHASTA-3 and SHASTA-4 successfully met the primary endpoint of triglyceride reduction versus placebo and m...
-
Utz Brands, Inc. Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – UTZ
LOS ANGELES--(BUSINESS WIRE)--Utz Brands, Inc. Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – UTZ...
-
Acacia Research to Release Second Quarter 2026 Financial Results on August 5, 2026
NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) (“Acacia” or the “Company”), which acquires and operates businesses across the industrial, energy and technology sectors, announced today that it will release its second quarter 2026 financial results before market open on August 5, 2026. The Company will host a conference call on August 5, 2026 at 8:00 a.m. ET / 5:00 a.m. PT to discuss its second quarter 2026 results. To access the live call, please dial 888-506-0062 (U.S. a...
-
MakeMyTrip Limited to Report Fiscal 2027 First Quarter Financial & Operating Results on August 03, 2026
GURUGRAM, India & NEW YORK--(BUSINESS WIRE)--MakeMyTrip Limited plans to report its fiscal 2027 first quarter financial and operating results before markets open on Monday, August 03, 2026....